Tectonic Therapeutic: Protein Engineering Platform For GPCRs
Group 1 - Tectonic Therapeutics focuses on discovering antibody therapeutics for GPCRs (G-protein coupled receptors) [1] - The company was founded in 2019 by Andrew Kruse and Timothy Springer [1] - Tectonic Therapeutics utilizes its GEODe platform to engineer biologics aimed at challenging targets [1]